MAYA KINMON: Open Payments
NPI 1235609108 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 8 payments from 7 companies in 2025. Trend: 2023 $138 · 2024 $270 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| Geron Corporation | 1 | $21 |
| TerSera Therapeutics LLC | 1 | $21 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: IMFINZI, XALKORI, RYTELO, Zoladex, PYLARIFY, VENCLEXTA.
Industry payments across OK — which companies pay providers there.
